The CD147 expression in CD4+ T cells is a novel biomarker for predicting efficacy of IL-17A inhibitor and psoriasis recurrence

Panpan Liu; Lei Li; Yehong Kuang; Wu Zhu; Jie Li; Xiang Chen; Cong Peng

doi:10.1002/ctm2.1568

Clinical and Translational Medicine ›› 2024, Vol. 14 ›› Issue (2) : e1568 DOI: 10.1002/ctm2.1568

LETTER TO THE JOURNAL

The CD147 expression in CD4⁺ T cells is a novel biomarker for predicting efficacy of IL-17A inhibitor and psoriasis recurrence

Panpan Liu ¹^,²^,³^,⁴^,⁵
, Lei Li ¹^,²^,³^,⁴^,⁵
, Yehong Kuang ¹^,²^,³^,⁴^,⁵
, Wu Zhu ¹^,²^,³^,⁴^,⁵
, Jie Li ¹^,²^,³^,⁴^,⁵
, Xiang Chen ¹^,²^,³^,⁴^,⁵^,^†
, Cong Peng ¹^,²^,³^,⁴^,⁵^,^†

Author information +

History +

PDF

Cite this article

Download citation ▾

Panpan Liu,Lei Li,Yehong Kuang,Wu Zhu,Jie Li,Xiang Chen,Cong Peng. The CD147 expression in CD4⁺ T cells is a novel biomarker for predicting efficacy of IL-17A inhibitor and psoriasis recurrence. Clinical and Translational Medicine, 2024, 14(2): e1568 DOI:10.1002/ctm2.1568

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

RIGHTS & PERMISSIONS

2024 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.